Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer
- 1 April 2002
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 186 (4) , 705-711
- https://doi.org/10.1067/mob.2002.121898
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- Prospective study on cervical neoplasia IV. Presence of HPV antibodiesInternational Journal of Cancer, 1999
- Human papillomavirus genotype as a major determinant of the course of cervical cancer.Journal of Clinical Oncology, 1998
- HPV-16-Related Proteins as the Serologic Markers in Cervical NeoplasiaGynecologic Oncology, 1998
- Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.Journal of Clinical Oncology, 1997
- Surface Conformational and Linear Epitopes on HPV-16 and HPV-18 L1 Virus-like Particles as Defined by Monoclonal AntibodiesVirology, 1996
- Serum IgG, IgM, and IgA Reactivity to Human Papillomavirus Types 11 and 6 Virus-like Particles in Different Gynecologic Patient GroupsThe Journal of Infectious Diseases, 1995
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodiesJournal of General Virology, 1994
- Serologic response in human papillomavirus‐associated invasive cervical cancerInternational Journal of Cancer, 1993